c-Ret inhibitor RPI-1, Purity ≥98%

Cat. No.: X23-10-ZQ188

c-Ret inhibitor RPI-1, Purity ≥98%

Synonym: 269730-03-2; RPI-1; RPI1; RPI 1; LJ66VPR7DB; RPI 1 [WHO-DD]; 1,3-Dihydro-3-[(4-hydroxyphenyl)methylene]-5,6-dimethoxy-2H-indol-2-one; c-Ret inhibitor

  • MDL: MFCD03852474
  • CAS Number: 269730-03-2
  • Compound CID: 1749978
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
RPI-1 primarily acts by blocking the ATP-binding site of the kinase domain of the RET protein, thereby inhibiting its autophosphorylation.
Molecular Weight
297.31
Molecular Formula
C17H15NO4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
RPI-1 can be utilized to research its role in inhibiting RET kinase and its implications in cancer therapy.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0